EliseAI Raises $250M in Series E funding New York City-based EliseAI is focused on automating systems in healthcare and housing. For healthcare, it offers a platform that automates conversations with patients over voice, email, text and chat. It also helps schedule appointments with doctors, and sends alerts about billing and payment. Its Series E round was led by Andreessen Horowitz (a16z) and included participation from Bessemer Venture Partners, Sapphire Ventures and Navitas Capital.
"We make really effective products that help couples get pregnant. Sometimes we get them pregnant too fast, which is great for being a human and for helping people. But not so great for business."
"It's just a new way of collecting the sample, it's not a new test," Teal Health CEO Kara Egan told Business Insider. "You can actually eliminate cervical cancer in the US, if we actually screen."
Azalea Vision's first closing of its â¬15M Series A funding round enables the clinical trials of its revolutionary eye care technology, aimed at FDA approval.